{"brief_title": "Ultraviolet Light Therapy for Systemic Lupus Erythematosus", "brief_summary": "OBJECTIVES: I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.", "detailed_description": "PROTOCOL OUTLINE: Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.", "condition": "Systemic Lupus Erythematosus", "intervention_type": "Procedure", "intervention_name": "ultraviolet A-1 light treatment", "criteria": "PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls --Prior/Concurrent Therapy-- No requirement for tetracycline or other photosensitizing drugs", "gender": "All", "minimum_age": "15 Years", "maximum_age": "70 Years", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00004375.xml"}